NATIONAL DOPING CASE
Lausanne (SUI), February 20, 2003 - The FINA Doping Panel,
composed of Mr. Harm Beyer (GER), Chairman, Mr. Ben Belkacem Farid (ALG),
Member, and Mr. Jean Lob (SUI), Member, has decided after a hearing on
this matter that Ms Anna Stylianou (CYP) was suspended for
four (4) years after a positive doping test on 19-norandrosterone
(metabolite of nandrolone) carried out on June 16, 2002.
Ms Stylianou's suspension starts on July 2, 2002.
Also according to FINA Rule DC 9.1.1 a retroactive sanction involving the
cancellation of all results achieved by the swimmer during the six-month
period before the collection of the positive sample is imposed.
An appeal may be submitted against this judgement at the Court of
Arbitration for Sport, Lausanne, Switzerland within one (1) month after
receipt of this judgement (FINA Rule C 12.8.3).
NEW LIST OF PROHIBITED
TO BE ENFORCED FROM JANUARY 1, 2003
Appendix A »
Appendix B »
Game", by WADA
The World Anti-Doping
Agency (WADA) launched an educational interactive program for athletes,
trainers and others involved
in sport. Through "The True Game", an interactive, multilingual (French
and English) game, players can enroll and test
their knowledge of doping issues.
The visitors of the site can also consult medical, scientific and
sociological information on doping and share their opinions on these
themes. All this can be found at
Lausanne, September 27, 2002 -
The FINA Doping Panel,
composed of Mr. Harm Beyer (GER), Chairman, Mr. Peter Kerr (AUS), Member,
and Mr. Jean Lob (SUI), Member, have decided after the hearings held on
September 26-27, 2002 in Lausanne (SUI) that Mr Vasilios DEMETIS (GRE)
and Ms Katerina BLIAMOU (GRE) were suspended each for four (4)
years after a positive doping test on 19-norandrosterone (metabolite of
nandrolone) carried out on September 5 and 6, 2001 respectively with the
occasion of the Mediterranean Games in Tunis (TUN).
FINA Rules DC 2.1 (a) and DC 9.1.1 Mr. Demetis’s suspension starts on
September 5, 2001. As for Ms Bliamou’s suspension, she already has served
six months and twelve days and the remaining time starts on May 8, 2002.
Also according to FINA Rule DC
9.1.1 a retroactive sanction involving the cancellation of all results
achieved by the swimmers during the six-month period before the collection
of the positive sample is imposed.
may be submitted against this judgement at the Court of Arbitration for
Sport, Lausanne, Switzerland within one (1) month after receipt of this
judgement (FINA Rule C 12.8.3).
BLIAMOU FULL WORDING
DEMETIS FULL WORDING
REJECTS COMPLAINT AGAINST
INTERNATIONAL OLYMPIC COMMITTEE and FINA
BY SWIMMERS BANNED FROM COMPETITIONS FOR DOPING
Press release from the
CLAUDIA POLL (CRC) CASE
June 6, 2002 -
Doping Panel, composed of Mr. Harm Beyer (GER), Chairman, Mr. Farid Ben
Belkacem (ALG), Member, and Mr. Jean Lob (SUI), Member, have decided after
the hearing held on May 31, 2002 in Lausanne (SUI) that Ms Claudia POLL
(Costa Rica) was suspended for having tested positive with the
substance Norandrosterone (Metabolites of Nandrolone) with the
occasion of a doping control test as part of the 2002 FINA Unannounced
Out-of-Competition Testing Programme on February 25th, 2002...
note that the athlete has appealed against the judgement made by FINA
Doping Panel to the Court of Arbitration for Sport (CAS)
CLAUDIA POLL (CRC) CASE
The four-year ban imposed on Claudia Poll confirmed
Court of Arbitration for Sport
Release from the (CAS)
Lausanne, 4 February 2003 -
The Court of Arbitration for Sport (CAS) has dismissed the appeal filed by
the Costarican swimmer Claudia Poll against the decision of the FINA
Doping Panel to sanction her further to a positive out-of-competition
doping control with nandrolone metabolites. Accordingly, the decision made
by the FINA Doping Panel on 3 June 2002, providing for a four-year
suspension commencing on 26 March 2002, is confirmed.
In the framework of the out-of-competition doping control programme
conducted by FINA, Claudia Poll underwent a doping test in February 2002.
The samples were sent to the IOC-Accredited Laboratory in Montreal,
Canada. The analyses performed by the laboratory revealed the presence of
norandrosterone in a concentration of 7.3 ng/ml ("A" sample) and 7.5 ng/ml
("B" sample). On the basis of the laboratory report, this case was
submitted to the FINA Doping Panel which decided to sanction the
Costarican swimmer with a four-year suspension commencing on 26 March 2002
and to cancel all her results achieved during the period from 26 September
2001 to 26 March 2002.
Claudia Poll appealed against that decision before the Court of
Arbitration for Sport. Her appeal was submitted to a Panel composed of
three CAS arbitrators : Dr. Martin Schimke, attorney at law in
Dortmund/Germany (President), Prof. Richard McLaren, Barrister at law in
London/Canada, Mr. Denis Oswald, attorney at law in Neuchatel/Switzerland.
A hearing was held in Lausanne on 12 December 2002 in the presence of the
athlete, her legal counsel and the FINA representatives. CAS announced its
final decision to the parties in the evening of 3 February 2003.
In her appeal, Claudia Poll put forward that the sampling procedure had
not been properly carried out, that the laboratory had failed to follow
some requirements with respect to the analysis procedure and that the
quantities of nandrolone detected in her urine samples were too low,
considering that this substance can be produced naturally by athletes.
In its decision, the CAS Panel confirmed the CAS case law with respect to
the principle of strict liability in doping cases : it is a matter for the
sports federation to prove the presence of a banned substance in the
athlete's body; if the federation is successful in proving this element,
there is a legal presumption that the athlete committed an offence,
whatever the intention of the athlete to commit such offence; the athlete
can reverse this presumption of guilt by showing that the case is not one
of doping and that he/she is innocent but it is for him/her to produce
The Panel found that Claudia Poll did not bring any convincing argument to
establish that the laboratory analyses were not correctly conducted.
Furthermore, the Panel considered that the athlete did not establish that
the sampling procedure was flawed. Finally, the arbitrators noted that the
quantity of nandrolone detected in Ms Poll's urine was above the threshold
of 5 ng/ml which is provided by the FINA Regulations.
UNANNOUNCED OUT-OF COMPETITION
DOPING CONTROL PROGRAMME
Combined urine and blood tests from June 2002
Lausanne, May 23, 2002 –
FINA will implement from the
beginning of June 2002 combined urine and blood tests for the detection of
the synthetic hormone erythropoietin (rEPO), darbopoietin (dEPO) and/or
related substances as part of its unannounced out-of competition doping
This important step forward in FINA’s fight against
doping is a direct consequence of the approval of these testing procedures
by the FINA Extraordinary Congress in Moscow (RUS) on April 2, 2002.
According to the FINA Rules, the decisions of the Congress take effect in
a two-month delay time, i.e. on June 2, 2002. From that date, the
athlete’s refusal to carry out these tests will be considered a doping
offence and will be duly sanctioned as per FINA Doping Rules.
Even before the Congress decision, FINA was the first
International Sport Federation to undertake from February 26, 2002
combined urine and blood tests as part of its unannounced out-of
competition doping control programme. Also, this new procedure was used
for the first time in a FINA competition, during the 6th FINA
World Swimming Championships (25m) in Moscow (RUS) from April 3-7, 2002
(154 tests, of which 98 were blood samples, all negative). In both cases,
the collection of the samples was depending on the athlete’s consent.
DOPING CONTROL PROGRAMME IN
6th FINA Swimming
World Championships (25m)
154 doping tests
conducted in Moscow at the occasion of the 6th FINA Swimming World
Championships (25m) were negative. From those 98 were blood tests, the
first conducted in FINA competitions to detect the presence of the
synthetic hormone erythropoietin (rEPO), darbopoietin and related
EXTRAORDINARY CONGRESS ADOPTED BLOOD TESTING - APRIL 2, 2002
Moscow, April 2, 2002 –
Delegates from 70 FINA
National Federations unanimously adopted during an Extraordinary Congress
held on April 2, 2002 in Moscow (RUS) the inclusion of both urine and
blood tests for testing the presence of the synthetic hormone
erythropoietin (rEPO), darbopoietin (dEPO) and/or related substances in
the FINA Doping Control Rules.
After being the first
International Federation to undertake from February 26, 2002 combined
urine and blood tests as part of the unannounced out-of competition doping
WILL TEST rEPO AND
DURING THE 6th FINA WORLD SWIMMING CHAMPIONSHIPS (25m)
Lausanne, February 26, 2002
- FINA (Fédération Internationale de Natation) announced today that
testing for the presence of the synthetic hormone erythropoietin (rEPO)
and related substances would take place in conjunction with the 6th
FINA World Swimming Championships (25m) to be held in Moscow (RUS) from
April 3-7, 2002...
FEDERATION DOPING CASE
TRENT BRAY (NZL)
March 22, 2002
of Arbitration for Sport rules:
1. The appeal
is partially upheld
decision of the FINA Doping Panel of June 14, 2001 is modified as follows:
Anthony Brent is suspended for a period of two years beginning on May 19,
2000. All results obtained by the Appellant six months prior to May 19,
2000 are cancelled.
3. The award
is pronounced without costs, except for the Court Office fee of CHF 500
(five hundred Swiss Francs) paid by Mr. Bray which is kept by the CAS.
party shall bear its own costs.
the relevant dates of Trent Bray National Doping Case (NZL)
NATIONAL FEDERATION DOPING
The Chinese swimmers Ying
Shan and Jiawei
Zhou are temporarily
suspended by the Chinese Swimming Association after they tested positive
for clenbuterol in a doping control carried out on January 31, 2002.
Chinese Swimming Association is now proceeding to a further investigation
on these two cases in order to decide the sanctions in accordance with the
NATIONAL FEDERATION DOPING
Vasileios Demetis (GRE)
appealed to the Greek Athletics Court.
(The Greek Swimming Federation, following its Rules and Regulations as
well as the FINA Doping Rules, decided to impose...
on CEZAR BADITA (ROM) DOPING CASE
FINA Doping Panel decided on 10 February 2001 the following conclusion
Cezar Badita Doping Case
A suspension of one (1) year,
shall be imposed on Mr. Cezar Badita, the
suspension to start with 10th February 2001.
Also a retroactive sanction involving the
Cancellation of all results achieved by the swimmer during
the period prior to the date the suspension takes effect
and extending back to six (6) months before 20 May 2000
is imposed. (see
NEW FINA LIST OF PROHIBITED
The new list of FINA
prohibited substances will take effect on September 1, 2001 and
will remain in effect until December 31, 2002.
FINA wishes to clarify its position in
relation to some press statements on Erythropoietin (EPO) tests
being conducted in connection with the Goodwill Games in Brisbane (AUS)
GH 2000 PROJECT
WORLD SWIMMING CHAMPIONSHIPS IN HONG KONG - APRIL 1999
As part of their campaign against the use of performance enhancing drugs
in swimming FINA invited GH-2000 to send a team out to Hong Kong to the
World Short course Swimming Championships in April 1999. GH-2000 offered
to provide confidential post-event blood testing to detect the use of GH
on swimmers on a voluntary basis. The information gathered was not to be
used as evidence of a doping offence but to be used by FINA to see if
there was any evidence to suggest that levels of markers of GH in blood
different in any way from those of other international athletes, and in
particular to assess whether there was any indication of doping amongst
any of the swimmers.
WITH REGARD TO DOPING CONTROL AT THE FINA SWIMMING WORLD CUP
COMPETITIONS IN BERLIN (GER) 5-6, FEBRUARY 2000.
Shortly after the end of the FINA Swimming
World Cup competition in Berlin (GER) 5-6 February 2000 FINA received
information about an incident in the doping control station at the
After having been approached by the
Australian Swimming Inc. and United States Swimming, the FINA Executive,
on February 8th , decided to request written reports from those present in
the doping control station.
Written reports have been provided FINA by
the following persons:
February 9th Dr. Eide Luebs, FINA Medical
February 16th Chief Thomas, TSC Member, FINA Delegate
February 17th Ian Thorpe (AUS) swimmer
February 21st Lenny Krayzelburg (USA) swimmer, John Skinner (USA) coach
February 23rd Don Talbot (AUS) coach
Faxletters in this matter have also been
received from Terry Gathercole, President, Australian Swimming, Inc, Vena
Murray, Executive Director, Australian Swimming Inc., and Chuck Wielgus,
Executive Director, United States Swimming, Inc.
The FINA Executive has considered the
reports from those persons directly involved in what happened in the
doping control station in Berlin. The following observations have been
1. No violation of the FINA Doping Control
Rules valid from 1 June 1999 has taken place at the doping control neither
by the FINA Medical Delegate nor by anybody else.
2. The following remarks made in the
reports requested special comments:
a) Although FINA Rule DC 6.4.5 requests
that “the competitor must show identification at the doping control
station” personal recognition of the competitor by the staff should be
b) The use of a German Swimming Federation Doping Control form containing
all necessary information does not invalidate the doping control.
c) There is no requirement in FINA Rule DC 8.1.6 that the competitors
shall place the A- and B- containers in a transport container.
d) The FINA Rule DC 6.2 requests that “any swimmer establishing or
breaking a World Record shall submit to doping control following the
race”. It is thus the responsibility of the swimmer to do so.
e) The use of Versapak kits has been approved by FINA.
3. The FINA Executive decided that no
action needs to be taken in the matter.
Without correct knowledge about the FINA DC
Rules, competitors and coaches should not interfere in the procedures at
the doping control station. Medical Delegates appointed by FINA are
responsible for the procedures and their decisions and actions must be
respected in order not to create any doubt regarding the correctness of
doping control at FINA Events. Remarks, if any, shall be directed to FINA
without involvement of any third person.
Lausanne, March 1, 2000
The IOC Medical Commission has distributed the following explanatory note
which modifies the reporting levels for Salbutamol and Ephedrines:
Salbutamol is classified as both a
stimulant and an anabolic agent.
The intent of unannounced
out-of-competition testing is to detect anabolic agents. The revised rules
on salbutamol consider it as anabolic agent when its concentration is
higher than 500 nanograms/millilitre and confirmed by enantiomeric
However, pending the acceptance of the
enantiomeric analysis by a peer-reviewed journal, only concentrations
higher than 1000 nanograms/millilitre will be considered a positive as an
anabolic agent until further notice. Samples that contain less than this
amount are not to be reported to the authorities for unannounced
In-competition testing is designed to
detect the use of salbutamol either as an anabolic agent or as a
stimulant. Whether or not the administration of salbutamol is declared is
an important issue for in-competition testing.
As always, it is the task of the
authorities to interpret the laboratory finding. In order not to overload
authorities with the need to confirm medical notifications of non-recent
inhaled use, laboratories do not need to report concentrations lower than
All concentrations above correspond to free
(non conjugated) salbutamol.
The pharmacology and urinary
pharmacokinetics of the ephedrines were reviewed. The consensus was that
the revised cutt-offs would detect all cases of doping where the
ephedrines were ingested on the day of competition.
FINA DOPING CONTROL REVIEW BOARD MEETING
17 January 2000, Lausanne (SUI)
The FINA Doping Control Review Board had its 2nd
Meeting on January 17 in Lausanne (SUI), with Dr. Andrew Pipe chairing the
meeting. Attending the Meeting were: Mr. Gunnar Werner (FINA Honorary
Secretary), Mr. Cornel Marculescu (FINA Executive Director), Prof. J.
Malcolm Cameron (FINA Medical Committee Honorary Secretary), Dr. Brian
Corrigan (AUS), Prof. Winton Arthur Hawksworth (RSA), Willem L. Mosterd
M.D., Ph.D. (NED), Prof. Wu Moutian (CHN), Prof. Jordi Segura (ESP). Only
Dr. Bowers was absent.
Some of the main issues discussed in the Meeting
were the Review of Application for Exemptions and Review and the protocol
for doping tests during Olympic Games and World Championships. The subject
of blood testing was also mentioned: Dr. Mosterd expressed an opinion that
blood collection is acceptable more in a moral way and it is faster,
whilst Dr. Segura said that he did not foresee blood testing replacing
urine analysis in the near future. Dr. Pipe stated that there are no
reliable tests yet developed and that for the moment this remains a
It was agreed that the next meeting of the DCRB
would be held on November 3, 2000, also in Lausanne (SUI).
DELEGATION VISIT TO CHINA
1-3 December 1999, Shanghai (CHN)
The FINA delegation was formed by:
Mr. Ross E. Wales, FINA Vice President, Head of Delegation
Mr. Roger Smith, FINA Vice President
Mr. Sam Ramsamy, FINA Bureau Member, FINA Spokesperson
Mr. Pipat Paniangvait, FINA Bureau Member
Mr. Cornel Marculescu, FINA Executive Director
The following is a summary of the FINA
Delegation meetings with representatives of the Chinese Swimming
Association led by Vice President, Mr. Shi Tianshu.
The delegation also met with
representatives of the Shanghai Swimming Association, athletes and coaches
and visited the various swimming centres in the city of Shanghai.
Shanghai, China - 1-3 December 1999. FINA concluded their follow-up
visit to China today where they received reports on doping control
instituted by the Chinese Swimming Association. Previously, the FINA
delegation visited China in 1995 and then again in 1998.
The delegation was pleased to learn that
most of the recommendations that were jointly agreed upon at the February
1998 meeting had been implemented. Also, the delegation was very satisfied
to hear that the Chinese Swimming Association, in conjunction with Chinese
Olympic Committee, has instituted blood sampling of swimmers as a pilot
Moreover, the FINA delegation learned of
more positive actions taken by the Chinese Swimming Association:
1. that the Chinese Swimming Association
has strengthened its publicity policy on anti-doping and has expanded its
2. that there has been a marked increase in
the number of unannounced out-of-competition tests. For 1999, 646 tests
have already been conducted, 217 in-competition and 429 unannounced
out-of-competition. In 1998 4 tests were returned positive and the
appropriate sanctions were imposed on the guilty swimmers.
3. that the regulations pertaining to the
allotment of cash awards were revised so that only 20% of the money is
paid to the swimmers and the coaches and the remainder is only paid four
years later, provided that the swimmer does not return a positive drug
4. that the Chinese Swimming Association
now engages in international exchanges so that the previous suspicions and
perceptions are corrected and clarified.
However, there was concern that certain
aspects of the initial agreement had either not been fulfilled completely
or that their implementation had not been reported to FINA. The following
was pointed out to the Chinese Swimming Association:
1. The issue surrounding the Chinese
Swimming Association's initial proposal to impose more severe sanctions
for doping offences than imposed by FINA has been partially diluted.
Because the FINA delegation understands the legal and social debate
arising out of such severe sanctions, such an amendment should have been
adopted in consultation with FINA.
2. There is a lack of fluidity in the
communication process between the Chinese Swimming Association and FINA.
FINA need to be informed in a timely manner about actions taken by the
Chinese Swimming Association. Poor communication has resulted in delays in
locating swimmers to conduct the unannounced out-of-competition doping
The FINA delegation understands and accepts
that doping in sport is a worldwide problem and not only specific to
Therefore, FINA and the Chinese Swimming
Association have agreed, as part of the on-going campaign against doping
in sport generally and doping in swimming specifically that:
1. the Chinese Swimming Association improve
their registration system so that the national and provincial systems are
2. an official should be appointed solely
to deal with doping matters; to connect swimmers with anti-doping
education resources and to disseminate the appropriate publicity material
to swimmers and coaches.
3. the anti-doping education programme will
be extended to all swimmers on the national and provincial levels.
4. The communication with FINA will be
prompt to avoid delays in the execution of decisions and in obtaining the
relevant information to clarify positions and perceptions.
5. All actions taken to intensify doping
control and strengthen the anti-doping education programmes must be
communicated to FINA as soon as possible. These must also be communicated
to the media so that the previous negative perceptions of Chinese Swimming
Association can be corrected.
Since February 1998 there have been six
positive results returned on the Chinese swimmers. This indicates that the
campaign against doping needs to be strengthened. Both parties are
committed to pursue anti-doping matters until the issue is brought to a
positive and favorable conclusion.